Care & Connect for Lung Cancer

This trial tests a program called Care & Connect to determine if it improves access to supportive care for people with lung cancer. Trained volunteers guide patients to resources, offer support, and assist with navigating the health system. Participants will receive either this special support or the usual care. Individuals with non-small cell or small cell lung cancer who have had their first medical appointment at the Princess Margaret Cancer Centre may qualify for this trial. The goal is to assess whether the Care & Connect program positively impacts the care and support of lung cancer patients. As an unphased trial, this study provides a unique opportunity to contribute to innovative care solutions that could enhance support for future patients.

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on providing support and information rather than altering medical treatments.

Research shows that programs like Care & Connect aim to help lung cancer patients by reducing stress and offering support. Although specific safety data on these programs is limited, they are generally considered safe because they provide information and support rather than medical treatment, making harm unlikely.

Despite the lack of specific safety data for Care & Connect, the program assists patients in finding resources and managing their care. Trained volunteers help patients navigate the healthcare system, and this support is usually well-received.

Researchers are excited about the Care & Connect program because it offers a unique approach to supporting lung cancer patients beyond standard medical treatments like chemotherapy, radiation, and surgery. Unlike traditional care, this program includes a 6-month lay navigation service where trained navigators provide personalized psychosocial support and help patients navigate the healthcare system. This approach aims to enhance patient well-being by connecting them with valuable resources and facilitating referrals to additional services, potentially leading to improved outcomes and quality of life for patients.

Research shows that navigation programs can improve lung cancer patients' access to care and support. Early findings suggest that these programs, such as Care & Connect, which participants in the intervention group of this trial will receive, may reduce stress and connect patients to essential health services. One study found that similar programs helped patients better understand and engage in their cancer care. Another study showed that patient navigation increased lung cancer screening rates among high-risk individuals. Although direct data on Care & Connect's effectiveness is limited, these results suggest it could be beneficial in meeting patient needs.³⁶⁷⁸⁹